Appropriations of the NCI

1938-1994



1938 through 1968 $1,690,550,220
1969185,149,500
1970190,486,000
14.0%1971230,383,000
$4,410,425,2201972378,794,000
1973492,205,000
1974551,191,500
1975691,666,0001
1976761,727,000
"TQ"152,901,0002
1977815,000,000
1978872,388,0003
1979937,129,000
19801,000,000,0004
1981989,355,0005
1982986,617,0006
86.0%1983987,642,0007
$27,142,476,0001984 1,081,581,0008
19851,183,806,000
19861,264,159,0009
19871,402,837,00010
19881,469,327,00011
19891,593,536,00012
19901,664,000,00013
19911,766,324,00014
19921,989,278,00015
19932,007,483,00016
19942,082,267,000
19952,135,119,000 17
Total (1938-1995)$31,552,901,220
Transition Quarter ("TQ") --

July 1, 1976 through September 30, 1976. The interim period in changing of the Federal Fiscal Year from July 1 through June 30 to October 1 through September 30.

1 Includes $18,163,000 for training funds provided by Continuing Resolution.

2 Includes $3,201,000 for training funds provided by Continuing Resolution.

3 Includes $20,129,000 for training funds provided by Continuing Resolution.

4 1980 appropriation authorized under a Continuing Resolution.

5 Reflects 1981 rescission of $11,975,000.

6 Amount included in continuing resolution. Includes $47,988,000 transferred to the National Institute of Environmental Health Sciences for the National Toxicology Program.

7 Appropriated under Continuing Resolution and Supplemental Appropriation Bill.

8 Includes $23,861,000 for training funds provided by a Continuing Resolution and $4,278,000 in a Supplemental Appropriation Bill.

9 Includes $6,000,000 from a Supplemental Appropriation Bill.

10 Authorized under Omnibus Continuing Resolution.

11 Authorized under Omnibus Continuing Resolution.

12 Appropriation prior to reduction contained in G.P. 517 (-$19,122,000) and G.P. 215 (-$2,535,000) and P.L. 100-436, Section 213, (-$1,013,000).

13 Appropriation prior to reduction contained in P.L. 101-166 (-$6,839,000) and P.L. 101-239 (-$22,829,000).

14 Appropriation prior to reductions in P.L. 101-517 (-$8,972,000 for salary and expense reduction; -$42,568,000 for across-the-board reduction).

15 Appropriation prior to reductions in P.L. 102-170 (-$21,475,000 for salary and expense reduction; -$1,262,000 for travel reduction; $15,000,000 transferred to other institutes for cancer research).

16 Appropriation prior to reductions in P.L. 102-294 (-$16,060,000 for .8% reduction to all line items, -$9,933,000 for S&E reduction, -$139,000 for consultant services reduction.)

17 Appropriation prior to reductions in PL 103-211 (-$1,883,000 for Procurement Reduction;-$116,000 for SLUC Reduction;-$1,052,000 for Bonus Pay Reduction). Includes $218,199,000 of AIDS funding.

Return to Historical Trends